Dasatinib and Crizotinib in Advanced Cancer

Clinical trial NCT01744652 · COMPLETED

Trial details

NCT number: NCT01744652
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancers

Start date: 2013-03-01
Primary completion: 2019-03-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.